Spring Bank Pharmaceuticals Inc
01748 Hopkinton, Spojené státy
Spring Bank Pharmaceuticals Inc Company Information
Hlavní informace
Spring Bank Pharmaceuticals is a clinical-stage biopharmaceutical company engaged in the discovery and development of a novel class of therapeutics using our proprietary small molecule nucleic acid hybrid (SMNH) chemistry platform. SMNH compounds are small segments of nucleic acids that the company designs to selectively target and modulate the activity of specific proteins implicated in various disease states. Spring Bank is developing its most advanced SMNH product candidate, inarigivir soproxil (formerly referred to as SB 9200), for the treatment of viral diseases, including hepatitis B virus (HBV), and other SMNH product candidates, including SB 11285, the company's lead immunotherapeutic agent for the treatment of selected cancers through the activation of the STimulator of Interferon Genes, or STING, pathway.
86 South Street Hopkinton
- Otevírací hodiny
-
Pondělí:08:30 - 17:00Úterý:08:30 - 17:00Středa:08:30 - 17:00Čtvrtek:08:30 - 17:00Pátek:08:30 - 17:00
- Parkování
- Společnost má parkoviště.
- Telefonní číslo
- +1508-473-5993
- Linki
- Sociální účty
- Klíčová slova
- farmaceutická společnost
Spring Bank Pharmaceuticals Inc Recenze
Jak hodnotíte tuto společnost?
Jste majitelem této společnosti? Jestliže ano, neztrácejte možnost aktualizovat profil své firmy, přidat produkty, nabídky a vyšší pozici ve vyhledávačích.